ADMA Biologics
ADMA

ADMA Biologics (ADMA) stock price, chart and financials

Price chart

−30.84% over 1Y
Oct 14, 2025Low $7.60 · High $20.38Oct 14, 2026

Financials

Company profile

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Frequently asked questions

  • Is ADMA Biologics (ADMA) profitable?

    Yes. ADMA Biologics earned $169.0M in net income over the trailing twelve months, a net margin of 32.98%.

  • How much revenue does ADMA Biologics (ADMA) make?

    ADMA Biologics generated $512.3M in revenue over the trailing twelve months, up 1.98% year over year.

  • What is ADMA's P/E ratio?

    ADMA Biologics trades at 13.7 times trailing twelve-month earnings, on an EPS of $0.72.

  • How do I buy stock in ADMA Biologics (ADMA)?

    ADMA trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.